Stockreport

Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel

Celularity Inc. - Class A  (CELU) 
PDF FLORHAM PARK, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced tha [Read more]